Literature DB >> 158539

Circadian variation of the streptozotocin-diabetogenic effect in mice.

S Candela, R E Hernandez, J J Gagliardino.   

Abstract

Streptozotocin was injected in normal mice every 4 h, during the day. Greatest number of diabetic animals were obtained at 16.00 h (95%) and lowest at 08.00 h (50%). Magnitude of hyperglycemia also showed similar distribution. This effect might be considered when planning its use for both experimental and clinical purposes.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 158539     DOI： 10.1007/bf01963323

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  10 in total

1.  Studies on the diabetogenic action of streptozotocin (NSC-37917).

Authors:  N RAKIETEN; M L RAKIETEN; M R NADKARNI
Journal:  Cancer Chemother Rep       Date:  1963-05

2.  An o-toluidine method for body-fluid glucose determination.

Authors:  K M DUBOWSKI
Journal:  Clin Chem       Date:  1962 May-Jun       Impact factor: 8.327

3.  The production and course of alloxan diabetes in the rat.

Authors:  A LAZAROW; S L PALAY
Journal:  J Lab Clin Med       Date:  1946-09

4.  Effect of fasting on the circadian rhythm of serum insulin levels.

Authors:  M T Pessacq; R G Mercer; O R Rebolledo; J J Gagliardino
Journal:  Chronobiologia       Date:  1976 Jan-Mar

5.  Treatment of Zollinger-Ellison syndrome with streptozotocin.

Authors:  F Stadil; G Stage; J F Rehfeld; F Efsen; K Fischerman
Journal:  N Engl J Med       Date:  1976-06-24       Impact factor: 91.245

6.  Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.

Authors:  L E Broder; S K Carter
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

7.  Plasma glucose levels in normal and adrenalectomized mice treated with streptozotocin and nicotinamide.

Authors:  P S Schein; R W Bates
Journal:  Diabetes       Date:  1968-12       Impact factor: 9.461

8.  Streptozotocin diabetes: time course of irreversible B-cell damage; further observations on prevention by nicotinamide.

Authors:  W Stauffacher; I Burr; A Gutzeit; D Beaven; J Veleminsky; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

Review 9.  Drugs producing diabetes through damage of the insulin secreting cells.

Authors:  C C Rerup
Journal:  Pharmacol Rev       Date:  1970-12       Impact factor: 25.468

10.  Circadian susceptibility rhythm of the rat to alloxan.

Authors:  R E Hernandez; J F Kühl; E Halberg; F Halberg; R N Shiotsuka; E Haus
Journal:  Chronobiologia       Date:  1978 Oct-Dec
  10 in total
  5 in total

Review 1.  Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models.

Authors:  M C Deeds; J M Anderson; A S Armstrong; D A Gastineau; H J Hiddinga; A Jahangir; N L Eberhardt; Y C Kudva
Journal:  Lab Anim       Date:  2011-04-08       Impact factor: 2.471

Review 2.  Guidelines on models of diabetic heart disease.

Authors:  Lisa C Heather; Anne D Hafstad; Ganesh V Halade; Romain Harmancey; Kimberley M Mellor; Paras K Mishra; Erin E Mulvihill; Miranda Nabben; Michinari Nakamura; Oliver J Rider; Matthieu Ruiz; Adam R Wende; John R Ussher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-03       Impact factor: 5.125

3.  Streptozotocin is equally diabetogenic whether administered to fed or fasted mice.

Authors:  Zunaira Z Chaudhry; David L Morris; Dan R Moss; Emily K Sims; Yien Chiong; Tatsuyoshi Kono; Carmella Evans-Molina
Journal:  Lab Anim       Date:  2013-06-10       Impact factor: 2.471

4.  Hepatic circadian-clock system altered by insulin resistance, diabetes and insulin sensitizer in mice.

Authors:  Huey-Ling Tseng; Shu-Chuan Yang; Shih-Hsien Yang; Kun-Ruey Shieh
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 5.  Animal Models of Diabetes-Associated Renal Injury.

Authors:  Zahra Samadi Noshahr; Hossein Salmani; Abolfazl Khajavi Rad; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2020-05-20       Impact factor: 4.011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.